Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.361 USD | +6.33% | +11.59% | -9.52% |
Financials (USD)
Sales 2024 * | 35.5M | Sales 2025 * | 46.5M | Capitalization | 10.22M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.29 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.22 x |
P/E ratio 2024 * |
-0.44
x | P/E ratio 2025 * |
-0.59
x | Employees | 142 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.32% |
Latest transcript on Telesis Bio, Inc.
1 day | +6.33% | ||
1 week | +11.59% | ||
1 month | -17.95% | ||
3 months | +9.06% | ||
6 months | -50.62% | ||
Current year | -9.52% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Gibson
FOU | Founder | 47 | 11-03-23 |
Eric Esser
CEO | Chief Executive Officer | 54 | 22-04-30 |
William Kullback
DFI | Director of Finance/CFO | 64 | 23-08-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jami Nachtsheim
BRD | Director/Board Member | 65 | 21-05-31 |
Director/Board Member | 65 | 21-04-30 | |
Gregory Herrema
BRD | Director/Board Member | 58 | 23-10-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.361 | +6.33% | 163,383 |
24-04-29 | 0.3395 | +6.63% | 25,552 |
24-04-26 | 0.3184 | -0.93% | 26,538 |
24-04-25 | 0.3214 | +0.03% | 26,908 |
24-04-24 | 0.3213 | -0.68% | 127,758 |
Delayed Quote Nasdaq, April 30, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.52% | 10.22M | |
+7.15% | 220B | |
+6.60% | 183B | |
+9.86% | 133B | |
+24.32% | 107B | |
-0.95% | 63.05B | |
+11.04% | 51.74B | |
+4.81% | 50.47B | |
-1.43% | 40.91B | |
+24.40% | 31.91B |
- Stock Market
- Equities
- TBIO Stock